Both in Biotechnology
Allogene Therapeutics vs Prime Medicine
Over the past year ALLO returned +27.6% and PRME returned −41.9%; their daily moves had a correlation of 0.41.
ALLO +27.6% PRME −41.9%Growth of $1, one year, split-adjusted
| Metric | ALLO | PRME |
|---|---|---|
| Price | $1.62 | $3.09 |
| Market cap | $559.7M | $560.5M |
| Today | −0.61% | +7.48% |
| 1 month | −19.8% | −14.4% |
| 6 months | −27.0% | −1.9% |
| Year to date | +18.2% | −11.0% |
| 1 year | +29.6% | −39.6% |
| Revenue growth (YoY) | — | +3.5% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −919.8% | −3649.0% |
| P/E (TTM) | — | — |
| Price / sales | 120.6× | 137.6× |
| Net cash | $332.6M | $95.1M |
| Dividend yield | — | — |
| Volatility (60d) | 57.7% | 85.9% |
| Short % of float | 21.7% | 33.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).